| Year |
Citation |
Score |
| 2019 |
Farrell M, Lichtenstein M, Crowley J, Filmyer D, Lázaro-Muñoz G, Shaughnessy R, Mackenzie IR, Hirsch-Reinshagen V, Stowe R, Evans J, Berg J, Szatkiewicz J, Josiassen R, Sullivan PF. THE GENOMICS OF HIGHLY TREATMENT RESISTANT SCHIZOPHRENIA European Neuropsychopharmacology. 29: S1006-S1007. DOI: 10.1016/J.Euroneuro.2017.08.401 |
0.308 |
|
| 2015 |
Scheuner MT, Peredo J, Benkendorf J, Bowdish B, Feldman G, Fleisher L, Mulvihill JJ, Watson M, Herman GE, Evans J. Reporting genomic secondary findings: ACMG members weigh in. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 17: 27-35. PMID 25394173 DOI: 10.1038/Gim.2014.165 |
0.346 |
|
| 2014 |
Fan Z, Greenwood R, Felix AC, Shiloh-Malawsky Y, Tennison M, Roche M, Crooks K, Weck K, Wilhelmsen K, Berg J, Evans J. GCH1 heterozygous mutation identified by whole-exome sequencing as a treatable condition in a patient presenting with progressive spastic paraplegia. Journal of Neurology. 261: 622-4. PMID 24509643 DOI: 10.1007/S00415-014-7265-3 |
0.301 |
|
| 2013 |
Caulfield T, Evans J, McGuire A, McCabe C, Bubela T, Cook-Deegan R, Fishman J, Hogarth S, Miller FA, Ravitsky V, Biesecker B, Borry P, Cho MK, Carroll JC, Etchegary H, et al. Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate. Plos Biology. 11: e1001699. PMID 24223516 DOI: 10.1371/Journal.Pbio.1001699 |
0.306 |
|
| 2012 |
Evans J. Abstract MS3-3: Navigating the Genome: Quandaries and Approaches to Dealing with Genomic Information Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-Ms3-3 |
0.332 |
|
| 2009 |
Irvin W, Carey L, Olajide O, Dees E, Raab R, Corso S, Chiu W, Walko C, Evans J, Weck K, McLeod H, Peppercorn J. Patients' Understanding of a CYP2D6 Tamoxifen Genotyping Study. Cancer Research. 69: 6082-6082. DOI: 10.1158/0008-5472.Sabcs-09-6082 |
0.311 |
|
| Show low-probability matches. |